Inventor · disambiguated record
Charles N. Serhan
Also filed as: SERHAN CHARLES · SERHAN CHARLES N · SERHAN CHARLES NICHOLAS
99 granted patents·34 pending applications·1,487 citations·filing 1984–2023
99Inventor score
Files withBRIGHAM & WOMENS HOSPITAL55SERHAN CHARLES N21BRIGHAM & WOMENS HOSPITAL INC17SOLUTEX NA LLC12UNIV CALIFORNIA3
Top patents by PatentIndex Score
133 records- 0196US7294728B2Lipoxin compounds and their use in treating cell proliferative disordersSERHAN CHARLES N·Filed 2005·Granted Nov 13, 2007·15 cites·4 claims
- 0296US7288569B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Oct 30, 2007·16 cites·4 claims
- 0396US6887901B1Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2003·Granted May 3, 2005·65 cites·40 claims
- 0496US5648512ALipoxin compoundsBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Jul 15, 1997·87 cites·5 claims
- 0595US7741369B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Jun 22, 2010·12 cites·10 claims
- 0695US7341840B2Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogsBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Mar 11, 2008·36 cites·8 claims
- 0795US6670396B2Aspirin-triggered lipid mediatorsBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Dec 30, 2003·81 cites·3 claims
- 0895US6569075B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted May 27, 2003·47 cites·50 claims
- 0995US5441951ALipoxin compoundsBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Aug 15, 1995·153 cites·20 claims
- 1094US11020406B2Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using sameSOLUTEX NA LLC·Filed 2020·Granted Jun 1, 2021·3 cites·18 claims
- 1194US10653703B2Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using sameSOLUTEX NA LLC·Filed 2016·Granted May 19, 2020·9 cites·20 claims
- 1294US8273792B2Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomersSERHAN CHARLES N·Filed 2006·Granted Sep 25, 2012·14 cites·20 claims
- 1394US6653493B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Nov 25, 2003·40 cites·32 claims
- 1493US6620919B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Sep 16, 2003·32 cites·32 claims
- 1592US7053230B2Aspirin-triggered lipid mediatorsSERHAN CHARLES N·Filed 2003·Granted May 30, 2006·39 cites·2 claims
- 1692US6750360B2Lipoxin compounds and their use in treating cell proliferative disordersBRINGHAM AND WOMEN S HOSPITAL·Filed 2001·Granted Jun 15, 2004·33 cites·18 claims
- 1792US6635776B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Oct 21, 2003·30 cites·18 claims
- 1891US4560514AInflammatory lipoxin A and anti-anflammatory lipoxin B compoundsSAMUELSSON BENGT·Filed 1984·Granted Dec 24, 1985·50 cites·3 claims
- 1990US11077084B2Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursorsSOLUTEX NA LLC·Filed 2021·Granted Aug 3, 2021·2 cites·14 claims
- 2090US8927747B214-hydroxy-docosahexaenoic acid compoundsSERHAN CHARLES N·Filed 2009·Granted Jan 6, 2015·11 cites·10 claims
- 2190US8349896B2Aspirin-triggered lipid mediatorsBRIGHAM & WOMENS HOSPITAL·Filed 2010·Granted Jan 8, 2013·12 cites·4 claims
- 2290US7709669B2Aspirin-triggered lipid mediatorsBRIGHAM & WOMENS HOSPITAL·Filed 2006·Granted May 4, 2010·14 cites·16 claims
- 2390US7030159B2Approach to anti-microbial host defense with molecular shields with EPA and DHA analogsBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Apr 18, 2006·30 cites·12 claims
- 2490US6710084B2Inhibition of TNFα-initiated neutrophil responseBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Mar 23, 2004·25 cites·9 claims
- 2590US6316648B1Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 1999·Granted Nov 13, 2001·51 cites·4 claims
- 2690US6048897ALipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 1996·Granted Apr 11, 2000·55 cites·13 claims
- 2789US9463177B2Compounds and methods for modulating vascular injuryUNIV CALIFORNIA·Filed 2013·Granted Oct 11, 2016·6 cites·22 claims
- 2889US8119691B2Method for treating airway hyper-responsiveness with lipoxin analogsSERHAN CHARLES N·Filed 2005·Granted Feb 21, 2012·12 cites·1 claims
- 2989US7737178B2Aspirin-triggered lipid mediatorsBRIGHAM AND WOMAN S HOSPITAL I·Filed 2008·Granted Jun 15, 2010·13 cites·5 claims
- 3089US5650435AModulation of inflammation related to columnar epitheliaFiled 1994·Granted Jul 22, 1997·55 cites·27 claims
- 3188US8008282B2Lipoxin analogs as novel inhibitors of angiogenesisBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Aug 30, 2011·15 cites·1 claims
- 3288US6720354B2Prevention of neutrophil recruitmentBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Apr 13, 2004·18 cites·6 claims
- 3387US10233167B214-hydroxy-docosahexaenoic acid compoundsBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Mar 19, 2019·4 cites·5 claims
- 3487US9416118B2Docosahexaenoyl ethanolamidesSERHAN CHARLES N·Filed 2012·Granted Aug 16, 2016·6 cites·18 claims
- 3587US9364454B2Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomersSERHAN CHARLES N·Filed 2012·Granted Jun 14, 2016·3 cites·13 claims
- 3687US7812054B2Lipoxin analogs and methods for the treatment of periodontal diseaseUNIV BOSTON·Filed 2009·Granted Oct 12, 2010·7 cites·34 claims
- 3787US7615576B2Prevention of neutrophil recruitmentBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Nov 10, 2009·6 cites·5 claims
- 3887US5079261AUse of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxisBRIGHAM & WOMENS HOSPITAL·Filed 1989·Granted Jan 7, 1992·54 cites·22 claims
- 3986US10568858B2Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursorsSOLUTEX NA LLC·Filed 2013·Granted Feb 25, 2020·3 cites·12 claims
- 4086US7825271B2Lipoxin compounds and their use in treating cell proliferative disordersBRIGHAM & WOMENS HOSPITAL·Filed 2007·Granted Nov 2, 2010·2 cites·4 claims
- 4186US7378444B2Analogues of lipid mediators derived from omega-3 PUFAs and methods of useBRIGHAM & WOMENS HOSPITAL·Filed 2003·Granted May 27, 2008·26 cites·9 claims
- 4285US6387953B1Inhibition of TNF-(α)-initiated neutrophil responseBRIGHAM AND WOMEN S HOPSITAL·Filed 2000·Granted May 14, 2002·21 cites·24 claims
- 4385US6177468B1Modulation of inflammation related to columnar epitheliaBRIGHAM & WOMENS HOSPITAL·Filed 2000·Granted Jan 23, 2001·16 cites·2 claims
- 4485US2023149423A1Compositions comprising omega-3 fatty acids, 17-hdha and 18-hepe and methods of using sameSOLUTEX NA LLC·Filed 2023·Application pending·0 cites
- 4584US8933270B2Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthmaBRIGHAM & WOMENS HOSPITAL·Filed 2013·Granted Jan 13, 2015·5 cites·33 claims
- 4684US7759395B2Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthmaBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Jul 20, 2010·5 cites·17 claims
- 4784US6703423B2Inhibition of TNFα-initiated neutrophil responseBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Mar 9, 2004·13 cites·9 claims
- 4884US6627658B2Lipoxin analogs as novel inhibitors of angiogenesisBRIGHAM & WOMENS HOSPITAL·Filed 2002·Granted Sep 30, 2003·19 cites·4 claims
- 4984US6433202B1Prevention of neutrophil recruitmentBRIGHAM & WOMENS HOSPITAL·Filed 2000·Granted Aug 13, 2002·12 cites·6 claims
- 5084US6353026B1Regulation of phospholipase D activityBRIGHAM & WOMENS HOSPITAL·Filed 2000·Granted Mar 5, 2002·15 cites·16 claims
Showing the top 50 of 133 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles N. Serhan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →